Sandro Anchisi

Sitten, VS 1951, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Past, present, and future perspectives in estrogen-receptor-low breast cancer.

Past, present, and future perspectives in estrogen-receptor-low breast cancer.

Journal: Critical reviews in oncology/hematology

Published: September 22, 2025

Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy.

Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy.

Journal: Cancers

Published: May 18, 2025

Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study.

Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study.

Journal: Cancer

Published: March 15, 2024

PARP inhibitors - A better selection of patients

PARP inhibitors - A better selection of patients

Journal: Revue medicale suisse

Published: May 17, 2023

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study.

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study.

Journal: Journal of geriatric oncology

Published: April 25, 2023

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.

Journal: Cancer biology & therapy

Published: March 27, 2023

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.

Journal: Cancers

Published: June 17, 2022

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.

Journal: European journal of cancer care

Published: December 11, 2021

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study.

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study.

Journal: Swiss medical weekly

Published: March 11, 2021

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).

Journal: BMC cancer

Published: October 09, 2020

Immunotherapy with immune checkpoint inhibitor and skin toxicity

Immunotherapy with immune checkpoint inhibitor and skin toxicity

Journal: Revue medicale suisse

Published: May 29, 2020

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16).

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16).

Journal: Journal of bone oncology

Published: November 01, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026